Our Work in Parliament

At Brain Tumour Research, we have progressed from protesting outside Westminster to actively working with Parliamentarians and political stakeholders to drive transformative action. 2026 has been a hugely impactful year for our community and at Brain Tumour Research we have played a full and active part in the development, production and delivery of;

In 2026, and in no small measure as a reaction to our years of campaigning and lobbying for change, Government has seized the opportunity to place research at the heart of transforming outcomes for brain tumour patients. We and other national charities proposed that the Department of Health create a new working group focused on overcoming the barriers to increasing the survival rate for brain tumour patients. This proposal was adopted by the Prime Minister on the 14th October 2026.  

We are optimistic that this renewed focus will help ensure discoveries in the laboratory actually make it to patients who so desperately need more options.  However, all progress must be viewed through the lens of our three overarching campaigning priorities: 

  • Government funding to support increased research spend to at least £45 million by 2029​ 
  • Government to enable growth of a sustainable research ecosystem to drive innovation in brain tumour research and the translation of this research to patient benefit​ 
  • An increase in number of brain tumour clinical trials, and percentage of patients accessing those trials in the UK​ 

    Our urgent work continues with partners across the charity sector, civil service, research community, and industry to make sure these priorities are realised.   

    To support this goal, we actively engage with parliamentarians and government officials in Westminster.  

We engage productively with Parliament in a variety of ways:

Meeting Ministers

Thanks to the tireless efforts and sustained campaigning by our supporters across the UK, we now meet directly with Ministers, to hold the Government accountable for consistent failure in supporting the brain tumour community. We use these meetings to hold ministers to account for the delivery of the past commitments that they have made in the brain tumour field. For example, in 2025 we challenged ministers about the lack of progress in the National Institute for Health and Research accepting proposals for new brain tumour scientific research. In 2026 we arranged for one of our supporters to meet the Health Minister to talk about her struggle to access information about clinical trials internationally after her son was diagnosed with glioblastoma. We also seek to share with them our evidence that highlights the urgent need for new treatments that can increase survival rates for brain tumours. 

Meeting MPs

MPs can raise awareness and drive change through mechanisms such as Westminster Hall debates, 10-Minute Rule Bills, Private Members’ Bills and other initiatives. By having MPs on our side, we significantly increase the likelihood of brain tumour issues being taken seriously at the highest levels of Government.  This is where our campaigners play such a vital role. Nearly every member of our APPG became involved with our community having heard from a constituent. Read about parents meeting with their MPs to prioritise brain tumours as a cancer of unmet need. 

You can really help us make a difference by writing to your MP. 

Send an email to campaigning@braintumourresearch.org  and we’ll give you all of the tools and advice you need to get involved. 

Coalitions

Working with charity coalitions has strengthened our calls for broader health policy changes that will benefit brain tumour patients. By uniting with other organisations, we amplify our voice. 

This collective action forces politicians to take notice and ensures that the needs of the brain tumour community are addressed within the wider health policy agenda. Together, we can achieve change greater than we could alone. 

We also work with a number of coalitions dedicated to influencing policy in the devolved nations. 

 

Some of coalitions we are a part of are : 

  • The Neurological Alliance 
  • National Council for Voluntary Organisations (NCVO) 
  • One Cancer Voice 
  • Less Survivable Cancer Taskforce 
  • Cancer 52 
  • The Northern Ireland Cancer Charities Coalition 
  • The Scottish Cancer Coalition 
  • Wales Cancer Alliance 

Consultation Responses

Consultations are a key part of the policy development process, where civil servants seek input from both experts and individuals directly impacted by policy. These allow for a broader understanding of the impact of potential legislation. 

They provide an opportunity for stakeholders, like us, to shape the direction of policy by contributing expert insights and highlighting the needs of those at the heart of the issue. 

We fed in our evidence to the National Cancer Plan as it was being compiled and were therefore delighted that when the report was launched in February 2026 rare cancers in general and specifically brain cancer received several mentions and ambitious recommendations to make improvements for our patient cohort and their families now and in the future. 

Collapsible content

Want to keep up to date with our Campaigning work? Subscribe to our weekly updates and get news straight to your inbox.